| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Shandong Hi-tech Spring Material Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.72 |
| 52 Week High | CN¥21.53 |
| 52 Week Low | CN¥10.83 |
| Beta | 0 |
| 11 Month Change | 5.01% |
| 3 Month Change | 29.17% |
| 1 Year Change | -24.71% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -39.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301292 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -1.6% | 4.7% | 3.9% |
| 1Y | -24.7% | -4.2% | 5.9% |
Return vs Industry: 301292 underperformed the CN Chemicals industry which returned -5.4% over the past year.
Return vs Market: 301292 underperformed the CN Market which returned 5.9% over the past year.
Price Volatility
| 301292 volatility | |
|---|---|
| 301292 Average Weekly Movement | 13.2% |
| Chemicals Industry Average Movement | 7.3% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in CN Market | 12.0% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 301292's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 301292's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | n/a | www.xyspec.com |
Shandong Hi-tech Spring Material Technology Co., Ltd. engages in the production and sale of lithium battery electrolyte solvents, pharmaceuticals, and food additives in the People’s Republic of China. The company was founded in 2002 and is based in Dongying, China.
Shandong Hi-tech Spring Material Technology Co., Ltd. Fundamentals Summary
| 301292 fundamental statistics | |
|---|---|
| Market cap | CN¥3.50b |
| Earnings (TTM) | -CN¥245.12m |
| Revenue (TTM) | CN¥3.40b |
1.0x
P/S Ratio-14.3x
P/E RatioIs 301292 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301292 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.40b |
| Cost of Revenue | CN¥3.40b |
| Gross Profit | CN¥4.37m |
| Other Expenses | CN¥249.49m |
| Earnings | -CN¥245.12m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.10 |
| Gross Margin | 0.13% |
| Net Profit Margin | -7.20% |
| Debt/Equity Ratio | 103.5% |
How did 301292 perform over the long term?
See historical performance and comparison